Kidney function may affect hepatitis b drug levels
NCT ID NCT07168356
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study gives a single dose of bepirovirsen to 32 adults with hepatitis B, some with kidney disease and some healthy. Researchers measure how much drug gets into the blood and how long it stays. The goal is to see if kidney problems change drug levels, which could affect future dosing recommendations.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
bepirovirsen
What this could lead to
If successful, this study could help doctors determine the right dose of bepirovirsen for hepatitis B patients with kidney problems.
What could go wrong
This is a very early, small study (32 people) focused on drug levels, not on treating hepatitis B. It may not lead to any treatment changes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
GSK Investigational Site
Orlando, Florida, 32809, United States
-
GSK Investigational Site
Tampa, Florida, 33603, United States
-
GSK Investigational Site
San Antonio, Texas, 78215, United States